Atlas Trials

Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation

Clinical trial NCT01906814 · UNKNOWN

Trial details

NCT number
NCT01906814
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Retinoblastoma
Start date
2013-08-01
Primary completion
2024-04-01
Enrollment
179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.